Correspondence 0001213900-24-011134 from BridgeBio Oncology Therapeutics, Inc. (BBOT)
BridgeBio Oncology Therapeutics, Inc.
Date: Feb. 7, 2024 · CIK: 0001869105 · Accession: 0001213900-24-011134
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-276591
Letter
Helix Acquisition Corp. II
c/o Cormorant Asset Management, LP
200 Clarendon Street, 52nd Floor
Boston, MA 02116
February 7, 2024
VIA EDGAR
Division of Corporation Finance
United States Securities and Exchange Commission
100 F Street, NE
Washington, D.C. 20549
Attn: Paul Cline
Isaac Esquivel
Ronald E. Alper
Pam Howell
Re: Helix Acquisition Corp. II
Registration Statement on Form S-1
Filed January 18, 2024, as amended
File No. 333-276591
Ladies and Gentlemen:
Pursuant to Rule 461 of the rules and regulations promulgated under the Securities Act of 1933, as amended, Helix Acquisition Corp. II respectfully requests that the effective date of the above-referenced Registration Statement be accelerated so as to permit it to become effective at 4:00 p.m. Washington D.C. time on February 8, 2024, or as soon thereafter as practicable.
Please call Joel L. Rubinstein of White & Case LLP at (212) 819-7642 to provide notice of the effectiveness of the Registration Statement.
[Signature Page Follows]
Very truly yours,
Helix Acquisition Corp. II
Show Raw Text
CORRESP
1
filename1.htm
Helix Acquisition Corp. II
c/o Cormorant Asset Management, LP
200 Clarendon Street, 52nd Floor
Boston, MA 02116
February 7, 2024
VIA EDGAR
Division of Corporation Finance
United States Securities and Exchange Commission
100 F Street, NE
Washington, D.C. 20549
Attn:
Paul Cline
Isaac Esquivel
Ronald E. Alper
Pam Howell
Re:
Helix Acquisition Corp. II
Registration Statement on Form S-1
Filed January 18, 2024, as amended
File No. 333-276591
Ladies and Gentlemen:
Pursuant to Rule 461 of the
rules and regulations promulgated under the Securities Act of 1933, as amended, Helix Acquisition Corp. II respectfully requests that
the effective date of the above-referenced Registration Statement be accelerated so as to permit it to become effective at 4:00 p.m. Washington
D.C. time on February 8, 2024, or as soon thereafter as practicable.
Please call Joel L. Rubinstein
of White & Case LLP at (212) 819-7642 to provide notice of the effectiveness of the Registration Statement.
[Signature Page Follows]
Very truly yours,
Helix Acquisition Corp. II
By:
/s/ Bihua Chen
Name:
Bihua Chen
Title:
Chief Executive Officer and Chairperson
cc: Joel L. Rubinstein, White & Case LLP